- Home
- ESP vs PLRX Comparison
ESP vs PLRX Comparison
Compare ESP & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- PLRX
- Stock Information
- Founded
- ESP 1928
- PLRX 2015
- Country
- ESP United States
- PLRX United States
- Employees
- ESP N/A
- PLRX N/A
- Industry
- ESP Industrial Machinery/Components
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- PLRX Health Care
- Exchange
- ESP Nasdaq
- PLRX Nasdaq
- Market Cap
- ESP 84.1M
- PLRX 84.7M
- IPO Year
- ESP N/A
- PLRX 2020
- Fundamental
- Price
- ESP $36.39
- PLRX $1.48
- Analyst Decision
- ESP
- PLRX Hold
- Analyst Count
- ESP 0
- PLRX 10
- Target Price
- ESP N/A
- PLRX $9.79
- AVG Volume (30 Days)
- ESP 26.2K
- PLRX 1.0M
- Earning Date
- ESP 05-12-2025
- PLRX 05-08-2025
- Dividend Yield
- ESP 2.73%
- PLRX N/A
- EPS Growth
- ESP 39.20
- PLRX N/A
- EPS
- ESP 2.67
- PLRX N/A
- Revenue
- ESP $45,965,588.00
- PLRX N/A
- Revenue This Year
- ESP N/A
- PLRX N/A
- Revenue Next Year
- ESP N/A
- PLRX N/A
- P/E Ratio
- ESP $13.69
- PLRX N/A
- Revenue Growth
- ESP 29.60
- PLRX N/A
- 52 Week Low
- ESP $20.20
- PLRX $1.10
- 52 Week High
- ESP $39.41
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- ESP 63.52
- PLRX 46.88
- Support Level
- ESP $34.90
- PLRX $1.22
- Resistance Level
- ESP $39.41
- PLRX $1.41
- Average True Range (ATR)
- ESP 1.41
- PLRX 0.09
- MACD
- ESP -0.04
- PLRX 0.02
- Stochastic Oscillator
- ESP 64.29
- PLRX 65.45
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.